Top Markets
#1 Zora Zora +34.71%
#2 0G 0G +21.45%
#3 Full Moon Full Moon +18.73%
#4 AI XOVIA AI XOVIA +17.63%
#5 Notcoin Notcoin +15.96%
#6 Helium Helium +14.00%
#7 Axelar Axelar +13.44%
#8 Wrapped NXM Wrapped NXM +12.47%
#9 rsERG rsERG +12.13%
#10 Yield Basis Yield Basis +11.03%
Coin of the day
Zora Zora
Settings
Language
ENGLISH
Currency
USD
Theme
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Rank in Stocks #12599
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Share Price
$9.09
Last synced: 2023-06-23
Market Cap
$567.77M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade CTI BioPharma Corp. (CTIC)

Category

Healthcare
Revenue for CTI BioPharma Corp. (CTIC)
Revenue in Aug 2026 TTM: 0
According to CTI BioPharma Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CTI BioPharma Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH